Christopher G. Twitty
Direttore Tecnico/Scientifico/R&S presso SKYE BIOSCIENCE, INC.
Provenienza dei contatti di primo grado di Christopher G. Twitty
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Medical/Nursing Services | 26 | |
| Public Company | Pharmaceuticals: Major | 13 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Christopher G. Twitty tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal General Counsel General Counsel Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Graduate Degree Undergraduate Degree | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Venturi Ventures, Inc.
 Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | Medical Specialties | Director/Board Member Director/Board Member | |
| RANGE IMPACT, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Cocoon Biotech, Inc.
 Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
PharmaNet, Inc.
 PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Medical Distributors | Corporate Officer/Principal General Counsel | |
Diagnostic Systems Laboratories, Inc.
 Diagnostic Systems Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Danaher Corp., Diagnostic Systems Laboratories, Inc. provides specialized medical products for clinical, research, academic, and veterinary markets. The company is based in Webster, TX. Diagnostic Systems Laboratories was acquired by Beckman Coulter, Inc., part of Danaher Corp. from June 30, 2011 on October 07, 2005. | Medical Specialties | Corporate Officer/Principal | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member | |
| University of British Columbia | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Masters Business Admin Doctorate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director of Finance/CFO General Counsel | |
| London School of Hygiene & Tropical Medicine | College/University | Corporate Officer/Principal | |
CellMedical SA
 CellMedical SA Medical/Nursing ServicesHealth Services CellMedical SA operates medical diagnostic laboratories. The company is headquartered in Thessaloniki, Greece. | Medical/Nursing Services | Chairman | |
| The European Commission | General Government | Corporate Officer/Principal | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Chairman Chief Executive Officer | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Biotechnology | Director/Board Member | |
| ARCH THERAPEUTICS, INC. | Medical Distributors | Chairman Director/Board Member | |
| EMERALD HEALTH THERAPEUTICS | Agricultural Commodities/Milling | Chief Executive Officer Director/Board Member Director/Board Member | |
PlaqueTec Ltd.
 PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
| AVROBIO, INC. | Biotechnology | Director/Board Member | |
| ONCIMMUNE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Emerald Health Sciences, Inc.
 Emerald Health Sciences, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Sciences, Inc. develops cannabinoid pharmaceutical drugs. It targets botanicals including medical & recreational and nutraceutical segments. The company was founded on July 31 2007is headquartered in Victoria, Canada. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Emerald Health Pharmaceuticals, Inc.
 Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Pharmaceuticals, Inc. engages in the development of medicines based on cannabinoid science. It focuses on discovering, developing, and commercializing proprietary cannabinoid-derived medicines. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Emerald Health Bioceuticals, Inc.
 Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Emerald Health Bioceuticals, Inc. engages in the provision of research and development of cannabis-free nutritional supplements that support the body’s endocannabinoid system (ECS). Its products include Endo Omega, Endo OmegaVegan, Endo Immune, Endo Sleep, Endo Bliss, Endo Calm, Endo Inflame, and Endo Brain. The company was founded on March 27, 2015 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chairman Chairman President | |
| SYNEOS HEALTH, INC. | Biotechnology | General Counsel Corporate Officer/Principal | |
Thrombolytic Science International LLC
 Thrombolytic Science International LLC Pharmaceuticals: MajorHealth Technology Thrombolytic Science International LLC operates as a vascular medicine and biotech company. The company was founded by Alexis Wallace and Victor Gurewich and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
PhESi LLC
 PhESi LLC Pharmaceuticals: MajorHealth Technology PhESi LLC provides drug and clinical development services for life sciences companies. The private company is based in East Lyme. | Pharmaceuticals: Major | Director/Board Member | |
AOBiome Therapeutics, Inc.
 AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman | |
| COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member | |
| SEELOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
COMPASS Pathfinder Holdings Ltd.
 COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017. | Financial Conglomerates | Director/Board Member | |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Founder | |
Perspectum Group Ltd.
 Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Director/Board Member | |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 29 |
| Regno Unito | 12 |
| Canada | 6 |
| Svezia | 2 |
| Grecia | 2 |
Settori
| Health Technology | 31 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 3 |
| Distribution Services | 3 |
Posizioni
| Director/Board Member | 186 |
| Corporate Officer/Principal | 104 |
| Chief Executive Officer | 52 |
| President | 51 |
| Independent Dir/Board Member | 46 |
Contatti più connessi
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Andrew Schwab | 45 |
| Anthony Maida | 32 |
| Avtar Dhillon | 25 |
| Praveen Tyle | 23 |
| Daniel O'Connor | 22 |
| Paul Grayson | 21 |
| Bob Rai | 19 |
| Gregory Mayes | 18 |
| Punit Dhillon | 15 |
| Margaret Dalesandro | 13 |
| Robert E. Ward | 13 |
| Sharron E. Gargosky | 12 |
| Sheela Mohan-Peterson | 11 |
| Richard Slansky | 10 |
- Borsa valori
- Insiders
- Christopher G. Twitty
- Connessioni Società
